||Mandalay Bay Las Vegas
||Tuesday, Dec 4, 2012 11:30 AM
||To register scroll down.
Hyponatremia is a common electrolyte disorder that can occur in isolation, but commonly occurs in association with severe comorbid conditions such as heart failure or cirrhosis. Hyponatremia results in increased hospital stays, worsening the prognosis of a number of severe medical conditions, and can be fatal. Because pharmacists play a core role in the management of hospitalized patients, they need to be proactive in advising on the various treatment options and therapies for hyponatremia patients. In addition, hyponatremia frequently goes undiagnosed and untreated by pharmacists and other medical practitioners.
This CE activity is intended to inform health-system pharmacists and other health care practitioners about new insights regarding the pathobiology of hyponatremia and the current and emerging options for the treatment of this condition. It will also provide new information about the latest clinical trial data that confirm the robust efficacy of vasopressin antagonists to normalize serum sodium concentration in patients with hyponatremia.
David S. Roffman, PharmD, BCPS/AQ Cardiology – Chair
Professor, Pharmacy Practice and Science
School of Pharmacy, University of Maryland
Therapeutic Consultant, Division of Cardiology
University of Maryland Medical System
Michael J. Cawley, PharmD, RRT, CPFT
Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences
J. Herbert Patterson, PharmD, FCCP
Professor of Pharmacy and Research Professor of Medicine
Executive Vice Chair, Division of Pharmacotherapy
and Experimental Therapeutics
University of North Carolina
Eshelman School of Pharmacy
Chapel Hill, NC
This activity is intended for hospital-based pharmacists.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Discuss the factors responsible for under-diagnosis and under-treatment of patients with hyponatremia and the subsequent clinical impact
- Describe the pathophysiologic abnormalities of water and electrolyte metabolism that result in development of hyponatremia
- Discuss the pathogenesis and underlying mechanisms of idiopathic hyponatremia (SIADH) and hyponatremia associated with heart or liver disease
- Apply the latest clinical trial findings about new therapeutic options for the management of hyponatremia in order to improve clinical outcomes
|Registration and Lunch:
||11:30 AM – 12:00 Noon
12:00 Noon – 1:30 PM
The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education.
This activity has been designated as a knowledge-based activity.
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.5 hours (0.15 CEUs) of continuing education credit (UAN 0418-9999-12-001-L04-P).
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Pharmacy Education (ACPE), and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Method of Participation
There are no fees associated with this program.
Event staff will be glad to assist you with any special needs (e.g. physical, dietary, etc.). Please email firstname.lastname@example.org at least 5 days prior to the program.
Jointly Sponsored By
Supported by an educational grant from Otsuka America Pharmaceutical, Inc.
By clicking the Registration Button below you are agreeing that you have read and understood the CE Statements above.
Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.